Yüklüyor......

An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters

The 2019 novel coronavirus, SARS-CoV-2, first reported in December 2019, has infected over 102 million people around the world as of February 2021 and thus calls for rapid development of safe and effective interventions, namely vaccines. In our study, we evaluated a DNA vaccine against SARS-CoV-2 in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Microorganisms
Asıl Yazarlar: Leventhal, Shanna S., Clancy, Chad, Erasmus, Jesse, Feldmann, Heinz, Hawman, David W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8151856/
https://ncbi.nlm.nih.gov/pubmed/34065996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9051040
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!